Metabolic Viral Host Properties

This study has been completed.
Sponsor:
Information provided by:
Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT00893308
First received: April 26, 2009
Last updated: May 10, 2009
Last verified: May 2009
  Purpose

Patients' metabolic properties may affect their immune response. This study aims to assess the effect of hosts' metabolic properties to viral infection.


Condition
HCV Infection

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Further study details as provided by Hadassah Medical Organization:

Detailed Description:

Blood samples were drawn from patients with Gaucher disease and healthy individuals, with and without HCV. Blood samples were tested for protein specific T cell proliferation, IFNg and IL-10 using ELISPOT assays, serum IFNg, IL-2, IL-6, IL-10 and IL-4 levels. FACS analysis was used for evaluation of lymphocytes subsets.

  Eligibility

Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Both male and female volunteers were recruited. with and without HCV infection, with and without Gaucher disease.

Criteria

Inclusion Criteria:

  • inform consent

Exclusion Criteria:

  • at patients request
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: Yaron Ilan, Hadassah medical organization
ClinicalTrials.gov Identifier: NCT00893308     History of Changes
Other Study ID Numbers: 481133- HMO-CTIL
Study First Received: April 26, 2009
Last Updated: May 10, 2009
Health Authority: Israel: Ministry of Health

ClinicalTrials.gov processed this record on August 28, 2014